無導管胰島素幫浦市場規模、佔有率和成長分析：按組件、分銷管道、最終用戶和地區分類－2026-2033年產業預測

2024 年全球無管胰島素幫浦市場價值為 14.2 億美元，預計到 2033 年將從 2025 年的 17.7 億美元成長至 102.8 億美元，預測期（2026-2033 年）的複合年成長率為 24.6%。

全球無導管胰島素幫浦市場的發展動力源自於患者對隱藏式靈活輸注胰島素的需求，以及自動化技術的進步，這些進步提升了血糖管理的安全性和便利性。該市場涵蓋了創新的貼片式穿戴式胰島素幫浦（無需導管即可輸注胰島素）以及整合了連續血糖監測儀和行動應用程式的平台。從早期貼片設計到如今市售設備的轉變，展現了該行業的快速發展，例如無線連接等功能可自動調節基礎胰島素劑量。年輕、活躍人群和輪班工作者越來越青睞這些解決方案，因為它們便於在運動期間和夜間進行治療。健保報銷政策帶來的可負擔價格鼓勵了醫療專業人員開立此類產品，也凸顯了策略夥伴關係、訂閱模式以及拓展新興市場的機會。

全球無管胰島素幫浦市場的成長要素

全球無管胰島素幫浦市場的主要促進因素之一是糖尿病在全球範圍內的日益普及。隨著糖尿病確診人數的持續成長，對高效且便利的胰島素輸注系統的需求也日益增加。無管胰島素幫浦消除了傳統輸注方式的不便，為使用者提供了更大的活動自由和柔軟性。此外，科技進步催生了更精密、便利、小巧的設備，進一步提升了消費者的興趣。糖尿病患者人數的成長以及創新產品的不斷湧現，共同推動了市場的顯著成長。

全球無管胰島素幫浦市場的限制因素

全球無導管胰島素幫浦市場的主要限制因素之一是這些先進設備的高成本，這可能會限制患者的使用，尤其是在發展中地區。除了購買無導管胰島素幫浦的經濟負擔外，持續的耗材和維護費用也會阻礙潛在用戶。此外，這些創新設備的保險覆蓋範圍有限，可能會進一步阻礙患者的接受度。加之醫護人員和病患對無導管胰島素幫浦益處的認知與了解不足，這些因素共同導致市場成長緩慢，各細分市場的普及率也較低。

無管胰島素幫浦市場的全球趨勢

全球無導管胰島素幫浦市場正呈現向個人化治療融合的顯著趨勢，製造商致力於透過先進技術改善患者照護。這包括即時血糖監測的無縫整合、用於個人化胰島素輸注的複雜演算法，以及根據個人偏好量身定做的以用戶為中心的設計元素。設備的設計越來越注重與個人健康數據和醫療團隊的協作，從而在不干擾患者日常生活的前提下實現個人化治療。此外，模組化韌體更新和與數位公司建立策略合作夥伴關係等趨勢正在加速產品開發和臨床檢驗，最終提升胰島素輸注系統的有效性和使用者體驗。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球無導管胰島素幫浦市場規模：按組件分類

• 儲液罐/泵
• 遙控器/控制器

全球無導管胰島素幫浦市場規模：依通路分類

• 醫院藥房
• 零售藥房
• 網路藥房

全球無導管胰島素幫浦市場規模：依最終用戶分類

• 醫院和診所
• 居家醫療
• 其他

全球無導管胰島素幫浦市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Insulet Corporation
• Medtronic
• Roche Holding
• Tandem Diabetes Care
• Ypsomed Holding
• Terumo Corporation
• Eli Lilly and Company
• Novo Nordisk
• Wuxi Apex Medical
• EOFlow
• Valeritas
• ViCentra
• Soylent
• SFC Energy
• PharmaSens
• Sooil Development
• MannKind Corporation
• Medtrum Technologies
• MicroTech Medical
• Sinomedical

結論與建議

Global Tubeless Insulin Pump Market size was valued at USD 1.42 Billion in 2024 and is poised to grow from USD 1.77 Billion in 2025 to USD 10.28 Billion by 2033, growing at a CAGR of 24.6% during the forecast period (2026-2033).

The global market for tubeless insulin pumps is significantly driven by patient demands for discreet and flexible insulin delivery, paired with technological advancements in automation that enhance glucose management safety and ease. This market encompasses innovative patch-type wearable pumps that administer insulin without tubing, as well as integrated platforms that utilize continuous glucose monitors and mobile applications. The transition from early patch designs to commercially available devices demonstrates rapid industry evolution, with features like wireless connectivity automating basal rate adjustments. Young, active individuals and shift workers increasingly prefer these solutions for their convenience during physical activities or overnight therapy. The affordability of pump devices through reimbursement options encourages healthcare practitioners to prescribe them, highlighting opportunities for strategic partnerships, subscription models, and expansion into emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tubeless Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tubeless Insulin Pump Market Segments Analysis

Global tubeless insulin pump market is segmented by component, distribution channel, end-user and region. Based on components, the market is segmented into Pod/Pump and Remote/Controller. Based on distribution channels, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on end-user, the market is segmented into Hospitals and Clinics, Home Care Settings and Others. Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tubeless Insulin Pump Market

One of the key market drivers for the global tubeless insulin pump market is the increasing prevalence of diabetes worldwide. As the number of individuals diagnosed with diabetes continues to rise, there is a growing demand for efficient and convenient insulin delivery systems. Tubeless insulin pumps offer enhanced mobility and flexibility for users, eliminating the inconvenience associated with traditional delivery methods. Furthermore, advancements in technology are leading to the development of more sophisticated, user-friendly, and compact devices, further boosting consumer interest. This combination of increasing diabetes cases and innovative product offerings is propelling significant growth in the market.

Restraints in the Global Tubeless Insulin Pump Market

One key market restraint for the global tubeless insulin pump market is the high cost associated with these advanced devices, which can limit accessibility for patients, particularly in developing regions. The financial burden of acquiring a tubeless insulin pump, along with the ongoing expenses for necessary supplies and maintenance, can dissuade potential users. Additionally, limited insurance coverage for these innovative devices may further inhibit patient adoption. Coupled with the lack of widespread awareness and understanding of their benefits among both healthcare providers and patients, these factors contribute to slower market growth and penetration in various demographics.

Market Trends of the Global Tubeless Insulin Pump Market

The Global Tubeless Insulin Pump market is witnessing a significant trend towards personalized therapy integration, where manufacturers are focusing on enhancing patient care through advanced technology. This involves the seamless incorporation of real-time glucose monitoring, sophisticated algorithms for tailored insulin dosing, and user-centric design elements that cater to individual preferences. Devices are increasingly designed to connect with personal health data and healthcare teams, facilitating customized therapy without disrupting patients' daily routines. Additionally, trends such as modular firmware updates and strategic collaborations with digital firms are accelerating product development and clinical validation, ultimately improving the effectiveness and user experience of insulin delivery systems.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Tubeless Insulin Pump Market Size by Component & CAGR (2026-2033)

• Market Overview
• Pod/Pump
• Remote/Controller

Global Tubeless Insulin Pump Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Tubeless Insulin Pump Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Tubeless Insulin Pump Market Size & CAGR (2026-2033)

• North America (Component, Distribution Channel, End-User)
  • US
  • Canada
• Europe (Component, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Distribution Channel, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuxi Apex Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EOFlow
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeritas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViCentra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soylent
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SFC Energy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaSens
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MannKind Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtrum Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTech Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations